Journal
CHEMMEDCHEM
Volume 7, Issue 5, Pages 815-822Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/cmdc.201100608
Keywords
actin cytoskeletons; alkaloids; apoptosis; bulbispermines; cancer; glioblastomas
Categories
Funding
- US National Institutes of Health (NIH) under the BRIN/INBRE and AREA [RR-16480, CA-135579]
- Italian Ministry of University and Research
- National Research Foundation (Pretoria, South Africa)
- Stellenbosch University (Stellenbosch, South Africa)
Ask authors/readers for more resources
The Amaryllidaceae alkaloid bulbispermine was derivatized to produce a small group of synthetic analogues. These, together with bulbispermines natural crinine-type congeners, were evaluated in vitro against a panel of cancer cell lines with various levels of resistance to pro-apoptotic stimuli. Bulbispermine, haemanthamine, and haemanthidine showed the most potent antiproliferative activities as determined by the MTT colorimetric assay. Among the synthetic bulbispermine analogues, only the C1,C2-dicarbamate derivative exhibited notable growth inhibitory properties. All active compounds were found not to discriminate between the cancer cell lines based on the apoptosis sensitivity criterion; they displayed similar potencies in both cell types, indicating that the induction of apoptosis is not the primary mechanism responsible for antiproliferative activity in this series of compounds. It was also found that bulbispermine inhibits the proliferation of glioblastoma cells through cytostatic effects, possibly arising from rigidification of the actin cytoskeleton. These findings lead us to argue that crinine-type alkaloids are potentially useful drug leads for the treatment of apoptosis-resistant cancers and glioblastoma in particular.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available